carbamazepine has been researched along with lacosamide in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (5.66) | 29.6817 |
| 2010's | 33 (62.26) | 24.3611 |
| 2020's | 17 (32.08) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Filipek, B; Kamiński, K; Kieć-Kononowicz, K; Latacz, G; Obniska, J; Rapacz, A; Łuszczki, JJ | 1 |
| Andres-Mach, M; Kamiński, K; Kieć-Kononowicz, K; Latacz, G; Rapacz, A; Zagaja, M; Łuszczki, JJ | 1 |
| Abram, M; Andres-Mach, M; Kamiński, K; Obniska, J; Rapacz, A; Zagaja, M; Łuszczki, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Filipek, B; Kamiński, K; Obniska, J; Rapacz, A | 1 |
| Bai, Y; Chen, X; Cuan, Y; Ding, Y; Fan, TP; He, X; Jia, P; Li, B; Li, Y; Liang, J; Liao, S; Meng, X; Qin, F; Shan, G; Sun, Y; Wang, S; Wei, X; Wu, B; Xiao, C; Xie, J; Yu, J; Zeng, M; Zhang, Q; Zhang, Y; Zhao, Y; Zhao, Z; Zheng, X; Zhu, Z | 1 |
| Errington, AC; Lees, G; Stöhr, T | 1 |
| Cummins, TR; Heers, C; Sheets, PL; Stoehr, T | 1 |
| Cawello, W; Eggert-Formella, A; Nickel, B | 1 |
| Arnaboldi, M; Belcastro, V; Prontera, P; Taborelli, A | 1 |
| Albus, C; Beck, H; Isom, L; Niespodziany, I; Opitz, T; Uebachs, M; Wolff, C | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Deuschl, G; Lang, N; Peckolt, H; Rothkegel, H | 1 |
| Jin, DI; Kang, JW; Lee, JE; Lee, SH; Lin, T | 1 |
| Duncan, JS; Markoula, S; Patsalos, PN; Ratnaraj, N; Sander, JW; Teotonio, R | 1 |
| Bonifácio, MJ; Hebeisen, S; Loureiro, AI; Palma, N; Pires, N; Soares-da-Silva, P; Spanswick, D; Whyment, A | 1 |
| Horváth, A; Kamondi, A; Szűcs, A | 1 |
| Kumar, D; Laurenza, A; Meador, KJ; Piña-Garza, JE; Wesnes, KA; Yang, H | 1 |
| Brandt, C; De Backer, M; Dedeken, P; Eckhardt, K; Elger, CE; Elmoufti, S; Rademacher, M; Tennigkeit, F | 1 |
| Borghs, S; Boyd, A; Byrnes, W; De Backer, M; Dedeken, P; Dilley, D; Echauz, J; Korb, P; LaRoche, S; Loring, DW; Meador, KJ; Story, T; Velez-Ruiz, N; Webster, E | 1 |
| Andres-Mach, M; Florek-Łuszczki, M; Patrzylas, P; Pyrka, D; Skalicka-Woźniak, K; Szpringer, M; Zagaja, M; Żółkowska, D; Łuszczki, JJ | 1 |
| Baulac, M; Brock, M; De Backer, M; Li, T; Rosenow, F; Terada, K; Toledo, M; Werhahn, KJ | 1 |
| Brigo, F | 1 |
| Bean, BP; Jo, S | 1 |
| Chan, EL; Chan, I; Chang, RS; Fong, GC; Fong, JK; Fung, BB; Fung, EL; Leung, H; Lui, CH; Poon, TL; Siu, D; Wong, HT; Yeung, E; Yung, AW; Zhu, CX | 1 |
| Tikhonov, DB; Zhorov, BS | 1 |
| Baheerathan, A; Brownlee, WJ; Chard, DT; Rugg-Gunn, F; Trip, SA | 1 |
| Abaroa, L; Alejandro Rodríguez-Quiroga, S; Arakaki, T; Garretto, NS; Melamud, L; Villa, AM | 1 |
| Cantero-Lozano, D; Garces-Anton, E; Garces-Redondo, M; Garrido-Fernandez, A; Lopez-Bravo, A; Marin-Gracia, M; Navarro-Perez, MP; Santos-Lasaosa, S | 1 |
| Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
| Brigo, F; Lattanzi, S | 1 |
| Alfano, G; Mangiardi, M | 1 |
| Ben-Menachem, E; Biton, V; Brock, M; De Backer, M; Gasalla, T; Grebe, HP; Jensen, L; Li, T; Steiniger-Brach, B; Terada, K | 1 |
| Chellun, D; De Backer, M; Dimova, S; Gasalla, T; Schmitz, B; Zhang, Y | 1 |
| Bozorg, A; Brandt, C; Dimova, S; Ferrò, B; Holmes, GL; Kälviäinen, R; Rosenow, F; Steiniger-Brach, B; Zhang, Y | 1 |
| Kaimovsky, IL; Mkrtchyan, VR | 1 |
| Goji, A; Kagami, S; Mori, T; Tayama, T; Toda, Y | 1 |
| Furukawa, G; Ishihara, N; Negishi, Y; Okumura, A; Takeuchi, T | 1 |
| Hayashi, T; Noguchi, Y; Tachi, T; Takaoka, M; Teramachi, H | 1 |
| Diomedi, M; Izzi, F; Lauretti, B; Liguori, C; Mercuri, NB; Pisani, A; Placidi, F; Posca, I; Rocchi, C | 1 |
| Araki, Y; Fukushima, Y; Imai, K; Kagawa, Y; Takahashi, Y; Terada, K; Yamamoto, Y | 1 |
| Chellun, D; De Backer, M; Dimova, S; Mintzer, S; Roebling, R; Steiniger-Brach, B; Zhang, Y | 1 |
| Chang, YP; Huang, LC; Li, KY; Yang, YH | 1 |
| Adamovich-Zeitlin, RH; Camp, EJ; Gross, RE; Jobst, BC; Kahana, MJ; Lega, BC; MacKenzie, TA; Meisenhelter, S; Quon, RJ; Song, Y; Sperling, MR; Steimel, SA; Testorf, ME | 1 |
| Panda, PK; Sharawat, IK | 1 |
| Benjamin, RN; Mathew, V; Mathews, DA; Miraclin, TA; Moorthy, M; Naresh, K; Prabhakar, AT; Prakash, JAJ; Sivadasan, A | 1 |
| Birnbaum, AK; Gerard, E; Kalayjian, L; Karanam, A; Matthews, A; McElrath, TM; Meador, KJ; Pennell, PB; Penovich, P | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
| Eguchi, Y; Ishikawa, N; Izumo, H; Kobayashi, Y; Okada, S; Tateishi, Y | 1 |
| Fan, X; Huang, G; Huang, J; Jin, X; Li, J; Pan, X; Wang, K; Wu, Q; Yan, N | 1 |
| Chellun, D; Dimova, S; Elmoufti, S; Floricel, F; Kubota, Y; O'Brien, TJ; Terada, K | 1 |
5 review(s) available for carbamazepine and lacosamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Consensus; Drugs, Generic; Epilepsy; Hong Kong; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Practice Guidelines as Topic; Societies, Medical; Triazines | 2017 |
The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy.
Topics: Adult; Affect; Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Humans; Lacosamide; Lamotrigine; Nitriles; Pyridones; Quality of Life; Topiramate | 2020 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
12 trial(s) available for carbamazepine and lacosamide
| Article | Year |
|---|---|
No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers.
Topics: Acetamides; Adolescent; Adult; Carbamazepine; Drug Interactions; Humans; Lacosamide; Male; Middle Aged; Young Adult | 2010 |
Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
Topics: Acetamides; Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy; Evoked Potentials, Motor; Female; Humans; Lacosamide; Male; Motor Cortex; Transcranial Magnetic Stimulation; Young Adult | 2013 |
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
Topics: Acetamides; Adolescent; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Memory, Short-Term; Neuropsychological Tests; Nitriles; Oxcarbazepine; Piracetam; Pyridones; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2016 |
Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Cholesterol; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Epilepsies, Partial; Humans; Lacosamide; Levetiracetam; Lipids; Lipoproteins, LDL; Male; Piracetam; Progesterone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroxine; Treatment Outcome | 2016 |
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Brain; Carbamazepine; Cognition; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Humans; Lacosamide; Male; Middle Aged; Neuropsychological Tests; Young Adult | 2016 |
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Epilepsy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lacosamide; Male; Middle Aged; Treatment Outcome; Young Adult | 2017 |
A clinical efficacy experience of Lacosamide on sleep quality in patients with Nocturnal Frontal Lobe Epilepsy (NFLE).
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Substitution; Epilepsy, Frontal Lobe; Female; Humans; Lacosamide; Male; Nocturnal Paroxysmal Dystonia; Oxcarbazepine; Voltage-Gated Sodium Channel Blockers | 2018 |
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dizziness; Double-Blind Method; Epilepsy; Female; Headache; Humans; Lacosamide; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2019 |
Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Delayed-Action Preparations; Depression; Double-Blind Method; Epilepsy; Female; Humans; Lacosamide; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2020 |
Lacosamide in patients with epilepsy of cerebrovascular etiology.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy; Female; Humans; Lacosamide; Male; Middle Aged; Treatment Outcome; Young Adult | 2020 |
Effects of lacosamide and carbamazepine on lipids in a randomized trial.
Topics: Anticonvulsants; Carbamazepine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Epilepsy; Humans; Lacosamide; Lipids; Triglycerides | 2020 |
Efficacy and tolerability of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed temporal lobe epilepsy: Post hoc analysis of a randomized, double-blind trial.
Topics: Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Epilepsy, Temporal Lobe; Humans; Lacosamide; Seizures; Treatment Outcome | 2023 |
36 other study(ies) available for carbamazepine and lacosamide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
Topics: Amides; Animals; Anticonvulsants; Benzylamines; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Electroshock; Humans; Imidazoles; Male; Mice; Microsomes, Liver; Molecular Structure; Motor Activity; Pentylenetetrazole; Propionates; Pyrrolidines; Rotarod Performance Test; Seizures; Small Molecule Libraries; Structure-Activity Relationship | 2015 |
Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Electroshock; HEK293 Cells; Humans; Mice; Models, Molecular; Molecular Structure; Motor Activity; Piperazines; Seizures; Structure-Activity Relationship; Succinimides | 2015 |
New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Injections, Intraperitoneal; Mice; Molecular Structure; Pain; Pain Measurement; Pentylenetetrazole; Piperazines; Pyrrolidinones; Seizures | 2016 |
Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.
Topics: Amides; Animals; Anticonvulsants; Calcium Channels; Drug Design; Humans; Injections, Intraperitoneal; Mice; Molecular Structure; Neurons; Pyrrolidines; Seizures | 2016 |
Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic α-asaronol esters: Design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study.
Topics: Allosteric Regulation; Animals; Anisoles; Anticonvulsants; Carbamazepine; Cinnamates; Dioxolanes; Drug Design; Drugs, Chinese Herbal; Esters; Humans; L-Lactate Dehydrogenase; Medicine, Chinese Traditional; Mice; Molecular Structure; Neuralgia; Polygala; Receptors, GABA-A; Structure-Activity Relationship; Valproic Acid | 2019 |
Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro.
Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetamides; Animals; Anticonvulsants; Carbamazepine; Convulsants; Electrophysiology; Epilepsy; Excitatory Amino Acid Antagonists; Extracellular Space; Female; In Vitro Techniques; Lacosamide; Male; Membrane Potentials; Patch-Clamp Techniques; Phenobarbital; Picrotoxin; Potassium Channel Blockers; Prohibitins; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Visual Cortex | 2006 |
Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Topics: Acetamides; Animals; Carbamazepine; Cell Line; Cells, Cultured; Humans; Lacosamide; Lidocaine; Male; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels | 2008 |
Lacosamide: new drug. Refractory partial epilepsy: optimise existing combinations.
Topics: Acetamides; Anticonvulsants; Atrioventricular Block; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Europe; Humans; Lacosamide; Randomized Controlled Trials as Topic | 2009 |
Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide | 2011 |
Loss of β1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents.
Topics: Acetamides; Action Potentials; Animals; Carbamazepine; Cells, Cultured; Lacosamide; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Knockout; Neurons; Protein Subunits; Voltage-Gated Sodium Channel beta-1 Subunit | 2012 |
Teratogenic potential of antiepileptic drugs in the zebrafish model.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Ethosuximide; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Teratogenesis; Topiramate; Triazines; United States; Valproic Acid; Zebrafish | 2013 |
Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Topics: Acetamides; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Induction; Epilepsy; Female; Humans; Lacosamide; Male; Middle Aged; Phenytoin; Retrospective Studies; Seizures; Valproic Acid | 2014 |
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Cell Line, Tumor; Dibenzazepines; Dose-Response Relationship, Drug; Hippocampus; Lacosamide; Male; Mice; Organ Culture Techniques; Oxcarbazepine; Time Factors; Voltage-Gated Sodium Channels | 2015 |
[The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Oxcarbazepine; Recurrence; Retrospective Studies; Treatment Outcome | 2015 |
Influence of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of various novel antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Drug Synergism; Electroshock; Fructose; Lacosamide; Lamotrigine; Male; Methoxsalen; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate; Triazines | 2016 |
Lacosamide monotherapy for newly diagnosed epilepsy.
Topics: Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Epilepsy; Humans; Lacosamide | 2017 |
Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
Topics: Acetamides; Carbamazepine; HEK293 Cells; Humans; Ion Channel Gating; Lacosamide; Membrane Potentials; NAV1.7 Voltage-Gated Sodium Channel; Time Factors | 2017 |
Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants.
Topics: Acetamides; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Benzhydryl Compounds; Binding Sites; Carbamazepine; Cocaine; Humans; Lacosamide; Lamotrigine; Lidocaine; Molecular Docking Simulation; NAV1.4 Voltage-Gated Sodium Channel; Phenols; Phenytoin; Piperazines; Protein Binding; Pyrimidines; Quinidine; Sodium Channel Blockers; Triazines | 2017 |
Neuromyelitis optica spectrum disorder related tonic spasms responsive to lacosamide.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Female; Humans; Lacosamide; Neuromyelitis Optica; Spasm; Treatment Outcome | 2017 |
Commentary on: Neuromyelitis optica spectrum disorder related tonic spams responsive to lacosamide.
Topics: Acetamides; Carbamazepine; Humans; Lacosamide; Neuromyelitis Optica | 2017 |
[Lacosamide associated with high-degree block in a patient with trigeminal neuralgia].
Topics: Aged; Anticonvulsants; Atrioventricular Block; Bradycardia; Carbamazepine; Cardiopulmonary Resuscitation; Combined Modality Therapy; Contraindications, Drug; Dibenzazepines; Drug Substitution; Electrocardiography; Heart Arrest; Humans; Lacosamide; Male; Nerve Block; Nociceptors; Pacemaker, Artificial; Trigeminal Neuralgia; Voltage-Gated Sodium Channel Blockers | 2018 |
Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair".
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |
Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair"?
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; Humans; Lacosamide | 2018 |
[Pharmacoeconomic aspects of monotherapy of focal epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Economics, Pharmaceutical; Epilepsies, Partial; Humans; Lacosamide; Lamotrigine; Oxcarbazepine; Retrospective Studies | 2019 |
Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Ring Chromosomes; Seizures; Treatment Outcome; Valproic Acid | 2020 |
Lacosamide for children with paroxysmal kinesigenic dyskinesia.
Topics: Adolescent; Carbamazepine; Child; Dystonia; Female; Humans; Lacosamide; Male; Membrane Proteins; Mutation; Nerve Tissue Proteins; Retrospective Studies | 2020 |
Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Topics: Anticonvulsants; Carbamazepine; Clobazam; Clonazepam; Databases, Factual; Drug Therapy, Combination; Epilepsy; Gabapentin; Humans; Japan; Lacosamide; Lamotrigine; Levetiracetam; Lorazepam; Pharmacovigilance; Phenytoin; Stevens-Johnson Syndrome; Valproic Acid | 2020 |
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Hand Strength; Humans; Lacosamide | 2020 |
Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Female; Humans; Lacosamide; Male; Phenobarbital; Phenytoin; Sodium Channel Blockers | 2020 |
Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Drug Resistant Epilepsy; Electrocorticography; Female; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Mental Recall; Middle Aged; Phenytoin; Time Factors; Topiramate; Zonisamide | 2021 |
Impact of carbamazepine and lacosamide on serum lipid levels.
Topics: Anticonvulsants; Carbamazepine; Lacosamide; Lipids | 2021 |
Epstein-Barr virus infection in a woman with aquaporin-4 seropositive neuromyelitis optica.
Topics: Adult; Aquaporin 4; Autoantibodies; Carbamazepine; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Lacosamide; Neuromyelitis Optica | 2021 |
Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregnancy; Prospective Studies; Topiramate; Zonisamide | 2022 |
Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting.
Topics: Acetamides; Adolescent; Anticonvulsants; Blood Cells; Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsy; Humans; Immunoglobulin A; Lacosamide; Lipids; Retrospective Studies; Treatment Outcome | 2022 |
Structural mapping of Na
Topics: Analgesics; Carbamazepine; Humans; Lacosamide; Pain; Protein Domains; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2023 |